Invention Grant
- Patent Title: N-bromotaurine solutions and emulsions against abnormal cells
-
Application No.: US17020168Application Date: 2020-09-14
-
Publication No.: US12076303B2Publication Date: 2024-09-03
- Inventor: Antonios Kyriakopoulos
- Applicant: NASCO AD BIOTECHNOLOGY LABORATORY
- Applicant Address: GR Pireus
- Assignee: Nasco Ad Biotechnology Laboratory
- Current Assignee: Nasco Ad Biotechnology Laboratory
- Current Assignee Address: GR Pireus
- Agency: Calderon Safran & Wright PC
- Agent Corrine Marie Pouliquen
- Priority: GR 160100072 2016.03.01
- Main IPC: A61K31/185
- IPC: A61K31/185 ; A61K9/00 ; A61K9/06 ; A61K9/08 ; A61K9/107 ; A61K47/36 ; A61K47/44 ; A61P17/00 ; A61P17/06 ; A61P31/22

Abstract:
In a method of producing aqueous solutions of N-bromotaurine (Taurine Bromanine, NBrT) with taurine with latter addition of NaOBr, and emulsions of these solutions with Stable Produced Olive Oil (S.P.O.O.), so to use against hyper-proliferative and abnormally differentiating cells of human and mammalian origin. In addition, due to the hyper-proliferation of keratinocytes in psoriatic skin, the methodology and subsequent use of the aqueous solutions and emulsions derived from this invention, containing NBrT and taurine, and S.P.O.O. against the lesions of psoriasis. With the method of this invention, the solutions derived and applied on cells in vitro beneficially provide maximization of NBrT anti-proliferative properties on abnormally differentiating and hyper-proliferating cells of human and mammalian origin by restoring NBrT anti-proliferative activity in a solution, whilst leaving unaffected the proliferation of normally dividing human fibroblasts.
Public/Granted literature
- US20210052527A1 N-BROMOTAURINE SOLUTIONS AND EMULSIONS AGAINST ABNORMAL CELLS Public/Granted day:2021-02-25
Information query